Effect of genetic variants in two chemokine decoy receptor genes, DARC and CCBP2, on metastatic potential of breast cancer

scientific article

Effect of genetic variants in two chemokine decoy receptor genes, DARC and CCBP2, on metastatic potential of breast cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2013PLoSO...878901Y
P356DOI10.1371/JOURNAL.PONE.0078901
P932PMC publication ID3829817
P698PubMed publication ID24260134
P5875ResearchGate publication ID258825568

P2093author name stringLei Fan
Chen Yang
Zhi-Ming Shao
Zhou-Luo Ou
Ke-Da Yu
Wen-Huan Xu
Ao-Xiang Chen
P2860cites workA high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions.Q52551923
Ionizing irradiation increases transcription of the von Willebrand factor gene in endothelial cellsQ71775695
The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activityQ77678719
Breast cancer progression and host polymorphisms in the chemokine system: role of the macrophage chemoattractant protein-1 (MCP-1) -2518 G alleleQ81341216
Chemokines and cancerQ83278273
Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECKQ22253297
Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptorQ24305554
The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptorQ24679431
Cancer statistics, 2010Q27860525
Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6Q28257066
Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediatorsQ30495417
Development and trends of surgical modalities for breast cancer in China: a review of 16-year dataQ31115506
Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressivenessQ33602017
Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphismQ34307777
Contribution of Duffy antigen to chemokine functionQ34438414
Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potentialQ34540077
Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokinesQ36183730
Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging ManualQ36383109
The inflammatory chemokines CCL2 and CCL5 in breast cancerQ37148637
Regulators of chemokine receptor activity as promising anticancer therapeuticsQ37184781
Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma.Q39474536
Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.Q39940205
Chemokine decoy receptor d6 plays a negative role in human breast cancerQ39949918
The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors.Q40481274
Multistep carcinogenesis of breast cancer and tumour heterogeneityQ41540149
The removal of leukocytes and platelets from whole blood.Q44677074
Clinicopathological features of the triple-negative tumors in Chinese breast cancer patientsQ46532483
Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?Q47300936
Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survivalQ47967779
Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a – b–) phenotypeQ48071663
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectmetastatic potentialQ122615215
P304page(s)e78901
P577publication date2013-11-15
P1433published inPLOS OneQ564954
P1476titleEffect of genetic variants in two chemokine decoy receptor genes, DARC and CCBP2, on metastatic potential of breast cancer
P478volume8

Reverse relations

cites work (P2860)
Q38998705ACKR2: An Atypical Chemokine Receptor Regulating Lymphatic Biology
Q40227745Atypical Chemokine Receptor 1 Polymorphism can not Affect Susceptibility to Hepatitis C Virus
Q45324784Atypical Chemokine Receptor 1 polymorphism cannot be used as an indicator of liver fibrosis progression in Hepatitis C virus positive patients
Q38747771Atypical chemokine receptors in cancer: friends or foes?
Q57790433Effect of functional genetic variants in chemokine decoy receptors on the recurrence risk of breast cancer
Q40202351Impact of genetic polymorphisms determining leukocyte/neutrophil count on chemotherapy toxicity
Q64924555Meta-Analysis of Autoimmune Regulator-Regulated Genes in Human and Murine Models: A Novel Human Model Provides Insights on the Role of Autoimmune Regulator in Regulating STAT1 and STAT1-Regulated Genes.
Q45762115ST6GalNAcII mediates the invasive properties of breast carcinoma through PI3K/Akt/NF-κB signaling pathway
Q64118708The Interplay Between Lymphatic Vessels and Chemokines
Q90649378The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses
Q38254356The potential to target CCL5/CCR5 in breast cancer.